ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Monarch Cement Company (PK)

Monarch Cement Company (PK) (MCEM)

184.90
0.90
(0.49%)
Closed April 28 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
184.90
Bid
184.68
Ask
184.90
Volume
629
184.90 Day's Range 184.90
111.00 52 Week Range 185.00
Market Cap
Previous Close
184.00
Open
184.90
Last Trade
1
@
184
Last Trade Time
Financial Volume
$ 116,302
VWAP
184.90
Average Volume (3m)
1,368
Shares Outstanding
3,689,767
Dividend Yield
1.47%
PE Ratio
16.69
Earnings Per Share (EPS)
11.08
Revenue
232.6M
Net Profit
40.88M

About Monarch Cement Company (PK)

Sector
Concrete,gypsum,plaster Pds
Industry
Concrete,gypsum,plaster Pds
Headquarters
Humboldt, Kansas, USA
Founded
1970
Monarch Cement Company (PK) is listed in the Concrete,gypsum,plaster Pds sector of the OTCMarkets with ticker MCEM. The last closing price for Monarch Cement (PK) was $184. Over the last year, Monarch Cement (PK) shares have traded in a share price range of $ 111.00 to $ 185.00.

Monarch Cement (PK) currently has 3,689,767 shares outstanding. The market capitalization of Monarch Cement (PK) is $682.24 million. Monarch Cement (PK) has a price to earnings ratio (PE ratio) of 16.69.

MCEM Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.41.31506849315182.5184.9182.5523183.40430622CS
40.90.4891304347831841851801696183.53748315CS
1232.921.64473684211521851421368171.38085437CS
2651.438.5018726592133.51851271282158.21784842CS
5269.960.78260869571151851111269143.61477578CS
15678.974.433962264210618590.451109121.49260499CS
260122.15194.66135458262.7518542117892.71706641CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

MCEM Discussion

View Posts
LouisDesyjr LouisDesyjr 7 years ago
Stock split, reverse and forward

I think the only reason they did it was so that they would have able to get below 300 shareholders for an instant, and stop formal reporting. They still publish financial statements, but do not have to spend the extra money on the higher level of reporting.

Louis J. Desy Jr.

👍️0
Renee Renee 9 years ago
MCEM one for 600 reverse split followed by a 600 for one forward split:

http://otce.finra.org/DailyList
👍️0
Nutinfancy Nutinfancy 9 years ago
Looking good today!!!!
👍️0
stockpickerup stockpickerup 10 years ago
Cement A Possible 60% Total Return

I own shares in this stock and was away on vacation or traveling the past month, but initially intended to post this when stock was $26 early August before their 10-Q for June 30. Despite stock up 12% since then, the potential remaining upside could be 60% total return including stock dividend (3.2% yield) over next two years. $45 price target along with 3.2% dividend yield from current $29.00 price.

Beware of two major risks of illiquidity in the shares and of disaster (explosion, fire, flood, major storm, tornado) impact on their sole plant in Kansas. Insider ownership is very high with the family and management owning approximately 19% of one class (OTCQB:MCEM) and 39% of the other class of shares (OTC:MCEMB). This, along with the shares traded OTC (over-the-counter), cause weeks to build a stake and even some wide bid/ask spreads occasionally.

Monarch Cement (OTCQB:MCEM) is a one hundred year old company with one large plant making ready-mix and cement, as well as cement concrete products. They produce and sell in the Midwest. Revenues are fairly evenly split between ready-mix and concrete (Portland cement and Masonry cement along with concrete products). The cement side is more interesting than ready-mix because of better margins (gross margins are two to three times higher in cement than ready-mix).

Environmental regulation pressures by the EPA (NESHAP) that triggered heavy capital expenditures the past couple years for compliance of pollution and emissions given mostly coal/coke fuel for manufacturing. Monarch Cement has already spent $17 million on this, which is a lot considering the market cap was only $100 million early August and little net debt ($14 million excluding pension/post retirement obligations of $32 million, but nearly $30 million in equity investments that could mostly offset it). Monarch Cement might have to spend another $11 million total for final compliance but also includes some spending on more modernization and efficiency. Their plant facility is more modern now but this EPA compliance pressure has put some smaller plants or competitors out of business in the US. My thesis is that a few peers have dropped out and the cement plants need to eventually pass along some of these compliance costs, so cement pricing could increase by 15% from summer 2014 to summer 2016. This provides a nice tailwind to operating leverage and the increase in capacity utilization in the peak season period (April-September). Should get a nice free cash flow and margin lift when it completes this emissions compliance spending in a few quarters.

Non-residential construction recovery is a critical part of the thesis as highways, bridges and roads need to be constructed and repaired. Residential housing recovery and even commercial construction improvement also contribute to ends needs of cement and ready-mix in concrete. Real construction spending in their region could grow 8-9% the next couple years or even higher including potential cement price increases.

June 30 quarter results had gross margins up to 25.5% from 20.5% a year ago due to cement side profitability expansion. Cement volumes rose 27% in June quarter, although easy year-ago comparison and weak first quarter ending March from annual downtime maintenance and repair made such sequential improvement possible. Ready-mix volumes rose nearly 13% but margins were slightly down there and still a concern.

It is not much of a stretch to envision $30 million of EBITDA potential despite some small divestiture/exit of two small business lines over the past year. Supply constraints and price increases over the next two years should help them possibly achieve this.

Replacement cost of their plant today could be $350-$400 million and tough entry barriers with permitting, compliance and geographical distribution radius constraints of maybe 300 miles where transportation costs are still economical.

A couple recent public M&A transactions sold for about 2.3x revenues. I imagine Monarch Cement could achieve $155 million revenues in 2017. Unclear if it is a takeover candidate due to high insider ownership and large voting impact (mainly from B shares). Their large plant with 1.1 million tons of cement capacity per year along with 250 acres of land for cement terminal, rock quarry minor acreage (although contracted to 3rd party) and equity investments could be attractive to Lafarge, Martin Marietta Materials/Texas Industries, Holcim, Eagle Materials, Vulcan Materials, Cementir, Cemex, Heidelberg Cement or Vicat S.A.

Valuation is cheap here at $29 stock price. I averaged three approaches of 6.5x $30 million EBITDA potential, $350 million replacement value at today's new costs and 2.3x recent peer transactions on $155 million revenue potential. This equates to roughly $300 million enterprise value versus $128 million today. Even using 6.6x potential $30 million EBITDA would be 55% upside before dividends that might add an additional 5-6% for 60% total return.

Lastly, there is no active sellside analyst coverage on this stock being published. I have not seen any sellside report on it. The company only publishes quarterly 10-Q and an annual report, but no quarterly results press release. This stock is very overlooked. 3.2% dividend yield, $30 million in equity investments as of June 30 (versus market cap $114 million) and some interesting tailwinds noted above make it very compelling. Liquidity remains an issue given OTC trading and high insider ownership. It has seasonal highs of revenues April-September then slows down during winter months due to less construction. Long-term highway funding is still a question mark, but seems fine through May '15 and hopeful longer term solution in place by then. Patience could be rewarded.

Disclosure: The author is long MCEM.
👍️0

Your Recent History

Delayed Upgrade Clock